Purchase Order HHSN272201200835P
Award Date 9/11/12
Potential Completion Date 9/20/12
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $3,938.22 firm fixed price purchase order is for the delivery of sequencing kits, with a completion date of September 14, 2015. The contract has no set-aside designation. Illumina has a history of providing sequencing systems, reagents, and...
- This federal contract award to Illumina, Inc. in the amount of $14,112.00 was issued by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). The contract is a firm fixed-price purchase order with no set-aside designation. Illumina, a manufacturer of genetic sequencing instruments and reagents, is providing a range of sequencing systems, consumables, and support services under this award to support genomic research and analysis across...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $5,626.82 firm fixed price delivery order is for the purchase of Illumina's TruSeq SBS Kit v3 - HS - 50-Cycle, which supports high-throughput DNA sequencing. The award has no set-aside designation and appears to align with NIAID's mission to support...
- This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $4,266.00, was awarded by the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) for the purchase of various Illumina sequencing systems, reagents, and related services. The contract is a firm fixed-price purchase order with no set-aside designation. Illumina has received...
- The U.S. Department of Health and Human Services National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,753.75 firm fixed-price delivery order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The award is not designated as a set-aside contract. Through this order, Illumina will provide biosequencing materials to support NIAID's biomedical research activities. Illumina has previously received prime federal contracts and subcontracts...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services (DHHS) to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The $12,466.18 firm fixed price delivery order is for the provision of bio materials to support NIAID's research and diagnostics efforts. Illumina is a well-established supplier of sequencing systems, reagents, and...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $11,236.05 firm fixed price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the delivery of Illumina Sequencing Kits and will be performed in San Diego, California. The award does not have a set-aside designation. Illumina has previously provided...
- This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc. for $48,000.00. The award is to provide service and support for Illumina's Genome Analyzer Illumina sequencing systems. Illumina is a manufacturer and provider of genetic and genomic sequencing and analysis instruments and reagents. This award does not have a set-aside designation. Illumina has a history of...
- This federal contract award to Illumina, Inc. was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The $77,483.79 fixed-price delivery order is for the purchase of NextSeq 500/550 High Output Kits (150 cycles) to support genomic sequencing and analysis. The award is not associated with a set-aside program. Through past federal contract awards, Illumina has provided a range of genomic sequencing...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents, for the purchase of TruSeq sequencing kits. The order, valued at $8,623.90, does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the National Institutes of Health,...